SCHEMBL1410184

SCHEMBL1410184

O=C(O)c1ccc2nc(-n3cc(C(=O)O)cn3)[nH]c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1192384 0.89 EGLN1 (0.81) EGLN1
SCHEMBL1192711 0.85 EGLN1 (1.00) EGLN1
SCHEMBL1192668 0.84 EGLN1 (1.00) EGLN1
SCHEMBL1193283 0.84 EGLN1 (1.00) EGLN1
SCHEMBL1192802 0.83 EGLN1 (1.00) EGLN1
SCHEMBL1193023 0.83 EGLN1 (1.00) EGLN1
SCHEMBL1192585 0.83 EGLN1 (1.00) EGLN1
SCHEMBL1192460 0.81 EGLN1 (0.82) EGLN1
SCHEMBL1193011 0.81 EGLN1 (0.82) EGLN1
SCHEMBL12875845 0.81 EGLN1 (0.73) EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2294066-A1 BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS Janssen Pharmaceutica, N.V. (BE) 2011-03-16 EP disclosed
WO-2009134750-A1 BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2009-11-05 WO disclosed